Further, as previously reported, BTLA blockade decreased the production of the immunosuppressive and tumor-promoting cytokine IL-10 by B cells, suggesting that targeting BTLA signaling may restore, at least in part, NK cell immune competence [48,68,69,70]. The gene discussed is BTLA; the disease is neoplasm.